Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Similar articles for PubMed (Select 24006149)

1.

The role of oral vitamin K antagonists in the outcome of infrainguinal bypass procedures.

Giannoukas AD, Paraskevas KI, Koutsias S, Argyriou C, Saleptsis V, Palombo D.

Angiology. 2014 Aug;65(7):568-73. doi: 10.1177/0003319713499816. Epub 2013 Sep 3. Review.

PMID:
24006149
2.

Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery.

Geraghty AJ, Welch K.

Cochrane Database Syst Rev. 2011 Jun 15;(6):CD000536. doi: 10.1002/14651858.CD000536.pub2. Review.

PMID:
21678330
3.

Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery.

Dörffler-Melly J, Büller HR, Koopman MM, Prins MH.

Cochrane Database Syst Rev. 2003;(4):CD000536. Review. Update in: Cochrane Database Syst Rev. 2011;(6):CD000536.

PMID:
14583924
4.

Antithrombotic therapy after infrainguinal bypass.

Maufus M, Pernod G.

J Vasc Surg. 2014 Nov;60(5):1367-75. doi: 10.1016/j.jvs.2014.07.105. Epub 2014 Oct 23. Review.

PMID:
25441694
5.

Outcome of infrainguinal single-segment great saphenous vein bypass for critical limb ischemia is superior to alternative autologous vein bypass, especially in patients with high operative risk.

Arvela E, Venermo M, Söderström M, Albäck A, Lepäntalo M.

Ann Vasc Surg. 2012 Apr;26(3):396-403. doi: 10.1016/j.avsg.2011.08.013. Epub 2012 Jan 27.

PMID:
22285375
6.

Comparison of graft patency, limb salvage, and antithrombotic therapy between prosthetic and autogenous below-knee bypass for critical limb ischemia.

Suckow BD, Kraiss LW, Stone DH, Schanzer A, Bertges DJ, Baril DT, Cronenwett JL, Goodney PP; Vascular Study Group of New England.

Ann Vasc Surg. 2013 Nov;27(8):1134-45. doi: 10.1016/j.avsg.2013.01.019. Epub 2013 Sep 5.

7.

Warfarin improves the outcome of infrainguinal vein bypass grafting at high risk for failure.

Sarac TP, Huber TS, Back MR, Ozaki CK, Carlton LM, Flynn TC, Seeger JM.

J Vasc Surg. 1998 Sep;28(3):446-57.

PMID:
9737454
8.

Interposition vein cuff for infragenicular prosthetic bypass graft.

Khalil AA, Boyd A, Griffiths G.

Cochrane Database Syst Rev. 2012 Sep 12;9:CD007921. doi: 10.1002/14651858.CD007921.pub2. Review.

PMID:
22972115
9.

Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality.

Henke PK, Blackburn S, Proctor MC, Stevens J, Mukherjee D, Rajagopalin S, Upchurch GR Jr, Stanley JC, Eagle KA.

J Vasc Surg. 2004 Feb;39(2):357-65.

PMID:
14743136
10.

Aspirin usage is associated with improved prosthetic infrainguinal bypass graft patency.

Gassman AA, Degner BC, Al-Nouri O, Philippi L, Hershberger R, Halandras P, Aulivola B, Milner R.

Vascular. 2014 Apr;22(2):105-11. doi: 10.1177/1708538112473977. Epub 2013 May 13.

PMID:
23535776
11.

The relative importance of graft surveillance and warfarin therapy in infrainguinal prosthetic bypass failure.

Brumberg RS, Back MR, Armstrong PA, Cuthbertson D, Shames ML, Johnson BL, Bandyk DF.

J Vasc Surg. 2007 Dec;46(6):1160-6. Epub 2007 Oct 24.

12.

Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery.

Conte MS, Bandyk DF, Clowes AW, Moneta GL, Seely L, Lorenz TJ, Namini H, Hamdan AD, Roddy SP, Belkin M, Berceli SA, DeMasi RJ, Samson RH, Berman SS; PREVENT III Investigators.

J Vasc Surg. 2006 Apr;43(4):742-751; discussion 751.

13.

Infrainguinal vein bypass graft revision: factors affecting long-term outcome.

Nguyen LL, Conte MS, Menard MT, Gravereaux EC, Chew DK, Donaldson MC, Whittemore AD, Belkin M.

J Vasc Surg. 2004 Nov;40(5):916-23.

PMID:
15557905
14.

A meta-analysis to compare Dacron versus polytetrafluroethylene grafts for above-knee femoropopliteal artery bypass.

Rychlik IJ, Davey P, Murphy J, O'Donnell ME.

J Vasc Surg. 2014 Aug;60(2):506-15. doi: 10.1016/j.jvs.2014.05.049. Epub 2014 Jun 25. Review.

PMID:
24973288
15.

Patency and limb salvage after infrainguinal bypass with severely compromised ("blind") outflow.

Desai TR, Meyerson SL, Skelly CL, MacKenzie KS, Bassiouny HS, Katz D, McKinsey JF, Gewertz BL, Schwartz LB.

Arch Surg. 2001 Jun;136(6):635-42.

PMID:
11386999
16.

Prevention of venous thromboembolism in orthopedic surgery with vitamin K antagonists: a meta-analysis.

Mismetti P, Laporte S, Zufferey P, Epinat M, Decousus H, Cucherat M.

J Thromb Haemost. 2004 Jul;2(7):1058-70.

PMID:
15219187
18.

Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Clagett GP, Sobel M, Jackson MR, Lip GY, Tangelder M, Verhaeghe R.

Chest. 2004 Sep;126(3 Suppl):609S-626S. Review.

PMID:
15383487
19.

Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery.

Brown J, Lethaby A, Maxwell H, Wawrzyniak AJ, Prins MH.

Cochrane Database Syst Rev. 2008 Oct 8;(4):CD000535. doi: 10.1002/14651858.CD000535.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;2:CD000535.

PMID:
18843613
20.

Meta-analysis of effect of single versus dual antiplatelet therapy on early patency of bypass conduits after coronary artery bypass grafting.

Nocerino AG, Achenbach S, Taylor AJ.

Am J Cardiol. 2013 Nov 15;112(10):1576-9. doi: 10.1016/j.amjcard.2013.07.017. Epub 2013 Sep 13. Review.

PMID:
24035160
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk